In the last 12 months, insiders at Imunon, Inc. ($IMNN) filed 75 transactions with the SEC: 3 open-market purchases totaling $79,730 and 0 sales totaling $0. Net insider sentiment: net buying.
Imunon, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Braun Donald P (Director) — 9 transactions totaling $48,248
- Dentzer James E (Director) — 8 transactions totaling $30,526
- Fritz Frederick J. (Director) — 8 transactions totaling $29,081
- Tardugno Michael H (Executive Chairman of Board) — 9 transactions totaling $25,750
- Lindborg Stacy (President and CEO) — 10 transactions totaling $24,500
View all SEC Filings for Imunon, Inc. (IMNN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Faller Douglas Vincent | Chief Medical Officer | A | Stock Option (Right to Buy) | 12667 | $0.00 | 12,667.0000 | 3,070,354 | 9999.99% | 0.41% |
| Jan. 2, 2026 | Fritz Frederick J. | Director | A | Stock Option (Right to Buy) | 5892 | $0.00 | 5,892.0000 | 3,070,354 | 9999.99% | 0.19% |
| Jan. 2, 2026 | Anwer Khursheed | Chief Scientific Officer | A | Stock Option (Right to Buy) | 15736 | $0.00 | 15,736.0000 | 3,070,354 | 9999.99% | 0.51% |
| Jan. 2, 2026 | Bragg Kimberly | CFO | A | Stock Option (Right to Buy) | 9050 | $0.00 | 9,050.0000 | 3,070,354 | 9999.99% | 0.29% |
| Jan. 2, 2026 | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 56187 | $0.00 | 56,187.0000 | 3,070,354 | 9999.99% | 1.83% |
| Jan. 2, 2026 | Tardugno Michael H | Executive Chairman of Board | A | Stock Option (Right to Buy) | 43821 | $0.00 | 43,821.0000 | 3,070,354 | 9999.99% | 1.43% |
| Jan. 2, 2026 | Dentzer James E | Director | A | Stock Option (Right to Buy) | 4405 | $0.00 | 4,405.0000 | 3,070,354 | 9999.99% | 0.14% |
| Jan. 2, 2026 | Braun Donald P | Director | A | Stock Option (Right to Buy) | 5881 | $0.00 | 5,881.0000 | 3,070,354 | 9999.99% | 0.19% |
| Jan. 2, 2026 | Pellizzari Christine A | Director | A | Stock Option (Right to Buy) | 4827 | $0.00 | 4,827.0000 | 3,070,354 | 9999.99% | 0.16% |
| Jan. 2, 2026 | Eylward Susan | General Counsel and Corp Sec | A | Stock Option (Right to Buy) | 8251 | $0.00 | 8,251.0000 | 3,070,354 | 9999.99% | 0.27% |
| Sept. 6, 2025 | Lindborg Stacy | President and CEO | M | Common Stock | 1667 | $0.00 | 3,818.0000 | 14,620,732 | 77.50% | 0.01% |
| Sept. 6, 2025 | Lindborg Stacy | President and CEO | M | Restricted Stock | 1667 | $0.00 | 0.0000 | 14,620,732 | 100.00% | 0.01% |
| Aug. 4, 2025 | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 14,620,732 | 9999.99% | 0.03% |
| Aug. 4, 2025 | Eylward Susan | General Counsel and Corp Sec | A | Stock Option (Right to Buy) | 417 | $0.00 | 417.0000 | 14,620,732 | 9999.99% | 0.00% |
| Aug. 4, 2025 | Tardugno Michael H | Executive Chairman of Board | A | Stock Option (Right to Buy) | 1667 | $0.00 | 1,667.0000 | 14,620,732 | 9999.99% | 0.01% |
| Aug. 4, 2025 | Dentzer James E | Director | A | Stock Option (Right to Buy) | 250 | $0.00 | 250.0000 | 14,620,732 | 9999.99% | 0.00% |
| Aug. 4, 2025 | Pellizzari Christine A | Director | A | Common Stock | 2248 | $9.20 | 2,248.0000 | 14,620,732 | 9999.99% | 0.02% |
| Aug. 4, 2025 | Pellizzari Christine A | Director | A | Stock Option (Right to Buy) | 250 | $0.00 | 250.0000 | 14,620,732 | 9999.99% | 0.00% |
| Aug. 4, 2025 | Braun Donald P | Director | A | Common Stock | 2040 | $9.20 | 3,747.0000 | 14,620,732 | 119.51% | 0.01% |
| Aug. 4, 2025 | Braun Donald P | Director | A | Stock Option (Right to Buy) | 250 | $0.00 | 250.0000 | 14,620,732 | 9999.99% | 0.00% |
| Aug. 4, 2025 | Fritz Frederick J. | Director | A | Common Stock | 3161 | $9.20 | 3,946.0000 | 14,620,732 | 402.68% | 0.02% |
| Aug. 4, 2025 | Dentzer James E | Director | A | Common Stock | 3318 | $9.20 | 3,318.0000 | 14,620,732 | 9999.99% | 0.02% |
| Aug. 4, 2025 | Fritz Frederick J. | Director | A | Stock Option (Right to Buy) | 250 | $0.00 | 250.0000 | 14,620,732 | 9999.99% | 0.00% |
| Aug. 4, 2025 | Anwer Khursheed | Chief Scientific Officer | A | Stock Option (Right to Buy) | 1667 | $0.00 | 1,667.0000 | 14,620,732 | 9999.99% | 0.01% |
| Aug. 4, 2025 | Bragg Kimberly | CFO | A | Stock Option (Right to Buy) | 667 | $0.00 | 667.0000 | 14,620,732 | 9999.99% | 0.00% |
| March 14, 2025 | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 14,620,732 | 9999.99% | 0.51% |
| March 14, 2025 | Fritz Frederick J. | Director | A | Stock Option (Right to Buy) | 3750 | $0.00 | 3,750.0000 | 14,620,732 | 9999.99% | 0.03% |
| March 14, 2024 | Anwer Khursheed | Chief Scientific Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2025 | Braun Donald P | Director | A | Stock Option (Right to Buy) | 3750 | $0.00 | 3,750.0000 | 14,620,732 | 9999.99% | 0.03% |
| March 14, 2025 | Eylward Susan | General Counsel and Corp Sec | A | Stock Option (Right to Buy) | 6250 | $0.00 | 6,250.0000 | 14,620,732 | 9999.99% | 0.04% |
| March 14, 2025 | Dentzer James E | Director | A | Stock Option (Right to Buy) | 3750 | $0.00 | 3,750.0000 | 14,620,732 | 9999.99% | 0.03% |
| March 14, 2025 | Tardugno Michael H | Executive Chairman of Board | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 14,620,732 | 9999.99% | 0.17% |
| March 14, 2025 | Pellizzari Christine A | Director | A | Stock Option (Right to Buy) | 3750 | $0.00 | 3,750.0000 | 14,620,732 | 9999.99% | 0.03% |
| Feb. 18, 2025 | Faller Douglas Vincent | Chief Medical Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 20, 2024 | Braun Donald P | Director | P | Common Stock | 25000 | $1.18 | 25,597.0000 | 0 | 4187.61% | 0.00% |
| Dec. 18, 2024 | Tardugno Michael H | Executive Chairman of Board | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| Sept. 6, 2024 | Lindborg Stacy | President and CEO | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 7, 2024 | Eylward Susan | General Counsel and Corp Sec | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 6, 2024 | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 63602 | $0.00 | 302,768.0000 | 0 | 26.59% | 0.00% |
| Sept. 6, 2024 | Braun Donald P | Director | A | Option to purchase Imunon common stock | 9072 | $0.00 | 28,905.0000 | 0 | 45.74% | 0.00% |
| Sept. 6, 2024 | Pellizzari Christine A | Director | A | Stock Option (Right to Buy) | 4964 | $0.00 | 23,630.0000 | 0 | 26.59% | 0.00% |
| Sept. 6, 2024 | Dentzer James E | Director | A | Stock Option (Right to Buy) | 3634 | $0.00 | 17,301.0000 | 0 | 26.59% | 0.00% |
| Sept. 6, 2024 | Fritz Frederick J. | Director | A | Stock Option (Right to Buy) | 6737 | $0.00 | 32,070.0000 | 0 | 26.59% | 0.00% |
| Sept. 6, 2024 | Tardugno Michael H | Executive Chairman of Board | A | Stock Option (Right to Buy) | 82926 | $0.00 | 394,759.0000 | 0 | 26.59% | 0.00% |
| Sept. 6, 2024 | Anwer Khursheed | Chief Scientific Officer | A | Stock Option (Right to Buy) | 40653 | $0.00 | 173,486.0000 | 0 | 30.60% | 0.00% |
| Aug. 15, 2024 | Tardugno Michael H | Executive Chairman of Board | P | Imunon Common Stock | 25000 | $1.03 | 353,346.0000 | 0 | 7.61% | 0.00% |
| Aug. 15, 2024 | Lindborg Stacy | President and CEO | P | Imunon Common Stock | 25000 | $0.98 | 264,166.0000 | 0 | 10.45% | 0.00% |
| June 12, 2024 | Fritz Frederick J. | Director | A | Stock Option (Right to Buy) | 3500 | $0.00 | 37,099.0000 | 0 | 10.42% | 0.00% |
| June 12, 2024 | Pellizzari Christine A | Director | A | Stock Option (Right to Buy) | 4500 | $0.00 | 18,666.0000 | 0 | 31.77% | 0.00% |
| June 12, 2024 | Dentzer James E | Director | A | Stock Option (Right to Buy) | 4500 | $0.00 | 13,667.0000 | 0 | 49.09% | 0.00% |
| June 12, 2024 | Braun Donald P | Director | A | Option to purchase Imunon common stock | 3500 | $0.00 | 23,430.0000 | 0 | 17.56% | 0.00% |
| June 12, 2024 | Tardugno Michael H | Executive Chairman of Board | A | Stock Option (Right to Buy) | 100000 | $0.00 | 328,346.0000 | 0 | 43.79% | 0.00% |
| June 12, 2024 | Anwer Khursheed | Chief Scientific Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 135,688.0000 | 0 | 22.59% | 0.00% |
| June 12, 2024 | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 112500 | $0.00 | 239,166.0000 | 0 | 88.82% | 0.00% |
| May 13, 2024 | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 112500 | $0.00 | 126,666.0000 | 0 | 794.16% | 0.00% |
| March 15, 2024 | Braun Donald P | Director | A | Option to purchase Imunon common stock | 3500 | $0.00 | 19,930.0000 | 0 | 21.30% | 0.00% |
| March 15, 2024 | Pellizzari Christine A | Director | A | Stock Option (Right to Buy) | 4500 | $0.00 | 14,166.0000 | 0 | 46.55% | 0.00% |
| March 15, 2024 | Fritz Frederick J. | Director | A | Stock Option (Right to Buy) | 3500 | $0.00 | 33,599.0000 | 0 | 11.63% | 0.00% |
| March 15, 2024 | Lindborg Stacy | Director | A | Stock Option (Right to Buy) | 4500 | $0.00 | 14,166.0000 | 0 | 46.55% | 0.00% |
| March 15, 2024 | Dentzer James E | Director | A | Stock Option (Right to Buy) | 4500 | $0.00 | 9,167.0000 | 0 | 96.42% | 0.00% |
| March 15, 2024 | Tardugno Michael H | Executive Chairman of Board | A | Stock Option (Right to Buy) | 12500 | $0.00 | 228,346.0000 | 0 | 5.79% | 0.00% |
| March 15, 2024 | Anwer Khursheed | Chief Scientific Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 110,688.0000 | 0 | 29.18% | 0.00% |
| March 15, 2024 | CHURCH JEFFREY WAYNE | CFO | A | Stock Option (Right to Buy) | 25000 | $0.00 | 120,950.0000 | 0 | 26.06% | 0.00% |
| Dec. 7, 2023 | Hazard Sebastien | Chief Medical Officer | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 7, 2023 | Hazard Sebastien | Chief Medical Officer | A | Common Stock | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| March 17, 2023 | Tardugno Michael H | Executive Chairman of Board | A | Stock Option (Right to Buy) | 25000 | $0.00 | 215,846.0000 | 0 | 13.10% | 0.00% |
| March 17, 2023 | Lindborg Stacy | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 9,666.0000 | 0 | 26.09% | 0.00% |
| March 17, 2023 | Dentzer James E | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 4,667.0000 | 0 | 74.99% | 0.00% |
| March 17, 2023 | Pellizzari Christine A | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 9,666.0000 | 0 | 26.09% | 0.00% |
| March 17, 2023 | Fritz Frederick J. | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 30,099.0000 | 0 | 7.12% | 0.00% |
| March 17, 2023 | Chow Pok Yu Augustine | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 18,429.0000 | 0 | 12.17% | 0.00% |
| March 17, 2023 | Braun Donald P | Director | A | Option to purchase Imunon common stock | 2000 | $0.00 | 16,430.0000 | 0 | 13.86% | 0.00% |
| March 17, 2023 | Le Goff Corinne | President and CEO | A | Stock Option (Right to Buy) | 90000 | $0.00 | 320,000.0000 | 0 | 39.13% | 0.00% |
| March 17, 2023 | CHURCH JEFFREY WAYNE | CFO | A | Stock Option (Right to Buy) | 40000 | $0.00 | 95,950.0000 | 0 | 71.49% | 0.00% |
| March 17, 2023 | Anwer Khursheed | Chief Scientific Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 85,688.0000 | 0 | 87.55% | 0.00% |